People in Pharmaceutics

51 researchers

Most active Upcoming first

Brenda Watt
Refeyn · as of Oct 2026
1 talk
Latest · Oct 27, 2026
Seeing the Unseen: Revealing Immune Complex Formation and Antibody Aggregation with Mass Photometry
Fabian Soltermann
Novartis Biomedical Research · as of Oct 2026
1 talk
Latest · Oct 27, 2026
Seeing the Unseen: Revealing Immune Complex Formation and Antibody Aggregation with Mass Photometry
Francesco Stellacci
Institute of Materials and Bioengineering Institute, École Polytechnique Fédérale de Lausanne, Switzerland · as of Oct 2026
1 talk
Latest · Oct 27, 2026
Small Molecule Stabilization of Proteins and Nanoparticles: Rethinking Colloidal Stabilization
Ben Boyd
Monash Institute of Pharmaceutical Sciences · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Douglas Kiehl
Purdue University · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Eric Appel
Stanford University · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Julie L. Gerberding
Foundation for the National Institutes of Health (FNIH) · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Samir Mitragotri
Harvard University · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Stephanie Barrett
Merck & Co., Inc. · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Stephan Schmidt
University of Florida · as of Oct 2026
1 conference
Latest · Oct 25, 2026
AAPS 2026 PharmSci 360
Nora Disis
University of Washington; Fred Hutchinson Cancer Center · as of Oct 2026
1 talk
Latest · Oct 22, 2026
Delivery as the rate-limiting step for cancer vaccines
Prasun Chakraborty
Genevation · as of Oct 2026
1 talk
Latest · Oct 22, 2026
Delivery as the rate-limiting step for cancer vaccines
Timothy Spear
Division of Oncology, Children's Hospital of Philadelphia · as of Oct 2026
1 talk
Latest · Oct 22, 2026
Delivery as the rate-limiting step for cancer vaccines
Amber Daniel
General Dynamics Information Technology, contractor supporting NIH ORIVA · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Anna Curle
Mass General Brigham and Harvard Medical School · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Anthony Letai
National Cancer Institute · as of Oct 2026
1 talk · 1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Chris Sheth
Aclairo · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Haleh Saber
FDA, Division of Hematology Oncology Toxicology · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Helena Hogberg-Durdock
NIH ORIVA, Division of the National Interagency Center for the Evaluation of Alternative Test Methods · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop
Imein Bousnina
Genentech · as of Oct 2026
1 workshop
Latest · Oct 20, 2026
Alternative Methodologies in Pharmaceutical Development Workshop

Researchers